Good practice

摘要

Unethical procedures, exploitation and inflated promises, that is what generally makes the headlines - and so it is with regenerative medicine and stem cells. Media reports have left the distinct impression that the research is rather dubious. First is the long-standing controversy over the source material: human embryos. Research banned by the most powerful man in the world - as US President George W. Bush was when he stopped federal support for such work in 2001 - must be a bit dodgy, right? Then there are the regular reports of companies that are exploiting vulnerable - and often seriously ill - patients with promises of expensive, but unproven, miracle cures.